Use of insulin pumps and closed‐loop systems among people living with diabetes: A narrative review of clinical and cost‐effectiveness to enable access to technology and meet the needs of payers
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Use of insulin pumps and closed‐loop systems among people living with diabetes: A narrative review of clinical and cost‐effectiveness to enable access to technology and meet the needs of payers
Authors
Keywords
-
Journal
DIABETES OBESITY & METABOLISM
Volume 25, Issue S2, Pages 21-32
Publisher
Wiley
Online
2023-04-13
DOI
10.1111/dom.15087
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Insurance Coverage for Emerging Diabetes Technologies: Payers' Perspective
- (2021) Tim Nolan et al. Diabetes Technology & Therapeutics
- Fully automated closed-loop glucose control compared with standard insulin therapy in adults with type 2 diabetes requiring dialysis: an open-label, randomized crossover trial
- (2021) Charlotte K. Boughton et al. NATURE MEDICINE
- Cost-effectiveness analysis of an Advanced Hybrid Closed Loop insulin delivery system in people with type 1 diabetes in Greece
- (2021) Vaia Lambadiari et al. Diabetes Technology & Therapeutics
- The Cost-Effectiveness of an Advanced Hybrid Closed-Loop System in People with Type 1 Diabetes: a Health Economic Analysis in Sweden
- (2021) Johan Jendle et al. Diabetes Therapy
- Fully closed-loop insulin delivery Improves glucose control of inpatients with type 2 diabetes receiving hemodialysis
- (2019) Lia Bally et al. KIDNEY INTERNATIONAL
- A modelling study of the budget impact of improved glycaemic control in adults with Type 1 diabetes in the UK
- (2019) P. Choudhary et al. DIABETIC MEDICINE
- Cost-Effectiveness Analysis of the MiniMed 670G Hybrid Closed-Loop System Versus Continuous Subcutaneous Insulin Infusion for Treatment of Type 1 Diabetes
- (2019) Johan Jendle et al. Diabetes Technology & Therapeutics
- Efficacy of Artificial Pancreas Use in Patients With Type 2 Diabetes Using Intensive Insulin Therapy: A Randomized Crossover Pilot Trial
- (2019) Nadine Taleb et al. DIABETES CARE
- Modelling potential cost savings from use of real‐time continuous glucose monitoring in pregnant women with Type 1 diabetes
- (2019) H. R. Murphy et al. DIABETIC MEDICINE
- Cost-Effectiveness of Sensor-Augmented Insulin Pump Therapy Versus Continuous Insulin Infusion in Patients with Type 1 Diabetes in Turkey
- (2019) Stéphane Roze et al. Diabetes Technology & Therapeutics
- Human regular U‐500 insulin via continuous subcutaneous insulin infusion versus multiple daily injections in adults with type 2 diabetes: The VIVID study
- (2019) George Grunberger et al. DIABETES OBESITY & METABOLISM
- Cost-effectiveness of sensor-augmented pump therapy in two different patient populations with type 1 diabetes in Italy
- (2018) A. Nicolucci et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis
- (2018) Eleni Bekiari et al. BMJ-British Medical Journal
- Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis
- (2018) Eleni Bekiari et al. BMJ-British Medical Journal
- Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study
- (2018) Araz Rawshani et al. LANCET
- Effectiveness of artificial pancreas in the non-adult population: A systematic review and network meta-analysis
- (2018) Vasilios Karageorgiou et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Closed-Loop Insulin for Glycemic Control in Noncritical Care
- (2018) NEW ENGLAND JOURNAL OF MEDICINE
- Closed-loop insulin delivery in inpatients with type 2 diabetes: a randomised, parallel-group trial
- (2017) Hood Thabit et al. Lancet Diabetes & Endocrinology
- Sustained Efficacy of Insulin Pump Therapy in Type 2 Diabetes: 9-Year Follow-up in a Cohort of 161 Patients: Table 1
- (2016) Julia Morera et al. DIABETES CARE
- Cost-Effectiveness of Sensor-Augmented Pump Therapy with Low Glucose Suspend Versus Standard Insulin Pump Therapy in Two Different Patient Populations with Type 1 Diabetes in France
- (2016) Stéphane Roze et al. Diabetes Technology & Therapeutics
- Cost-effectiveness of continuous subcutaneous insulin infusion in people with type 2 diabetes in the Netherlands
- (2016) S. Roze et al. JOURNAL OF MEDICAL ECONOMICS
- Cost-effectiveness of continuous subcutaneous insulin infusion versus multiple daily injections of insulin in Type 1 diabetes: a systematic review
- (2015) S. Roze et al. DIABETIC MEDICINE
- Insulin pump therapy, multiple daily injections, and cardiovascular mortality in 18 168 people with type 1 diabetes: observational study
- (2015) I. Steineck et al. BMJ-British Medical Journal
- Insulin pump therapy, multiple daily injections, and cardiovascular mortality in 18 168 people with type 1 diabetes: observational study
- (2015) I. Steineck et al. BMJ-British Medical Journal
- Long-term health economic benefits of sensor-augmented pump therapy vs continuous subcutaneous insulin infusion alone in type 1 diabetes: a UK perspective
- (2015) Stéphane Roze et al. JOURNAL OF MEDICAL ECONOMICS
- Insulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes (OpT2mise): a randomised open-label controlled trial
- (2014) Yves Reznik et al. LANCET
- Projection of Long Term Health-Economic Benefits of Sensor Augmented Pump (Sap) Versus Pump Therapy Alone (Csii) In Type 1 Diabetes, A Uk Perspective
- (2014) S. Roze et al. VALUE IN HEALTH
- Projection of Long Term Health Economic Benefits of Sensor Augmented Pump (Sap) Versus Pump Therapy Alone (Csii) In Uncontrolled Type 1 Diabetes In France
- (2014) S. Roze et al. VALUE IN HEALTH
- Feasibility of Closed-Loop Insulin Delivery in Type 2 Diabetes: A Randomized Controlled Study
- (2013) Kavita Kumareswaran et al. DIABETES CARE
- O42 Traitement par pompe à insuline dans le diabète de type 2 (DT2): 12 ans de suivi d’une cohorte de 50 patients
- (2012) L. Charras et al. DIABETES & METABOLISM
- P289 Résultats métaboliques obtenus à 2 ans sous pompe à insuline ambulatoire chez des diabétiques de type 2 en échec d’insulinothérapie optimisée
- (2012) J.P. Courrèges et al. DIABETES & METABOLISM
- Use of Insulin Pump Therapy in Patients with Type 2 Diabetes After Failure of Multiple Daily Injections
- (2012) Matthew Leinung et al. Endocrine Practice
- Reduction of Glycosylated Hemoglobin Following 6 Months of Continuous Subcutaneous Insulin Infusion in an Indian Population with Type 2 Diabetes
- (2009) Jothydev Kesavadev et al. Diabetes Technology & Therapeutics
- Incidence trends for childhood type 1 diabetes in Europe during 1989–2003 and predicted new cases 2005–20: a multicentre prospective registration study
- (2009) Christopher C Patterson et al. LANCET
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started